The Conversation (0)
Myomo, a medical robotics company, has submitted a Form 1-A with the Securities and Exchange Commission regarding its proposes initial public offering on the NYSE.
Myomo, a medical robotics company, has submitted a Form 1-A with the Securities and Exchange Commission regarding its proposes initial public offering on the NYSE.
According to the press release:
“The number of shares to be offered and the price range for the proposed offering have not yet been determined. Myomo intends to apply for listing its common stock on the NYSE MKT under the ticker symbol ‘MYO.'”
The press release goes on to state:
“Myomo specializes in myoelectric orthotics for people with neuromuscular disorders. Myomo developed the MyoPro® product line which is based on its patented myoelectric technology developed at the Massachusetts Institute of Technology (MIT). The orthosis, available on a physician’s order, is a non-invasive, powered brace used for the purpose of supporting and moving a patient’s weak or deformed arm and hand to re-enable functional activities.”
Read the full press release here.